Scientific Respiratory Symposium, Paris June 2010

Overview

Journal J Asthma Allergy

Publisher Dove Medical Press

Date 2011 Jul 28

PMID 21792320

Citations 1

Authors

Gavin Dalglish

Graham Priestley

Affiliations

Soon will be listed here.

Abstract

At a 2010 Respiratory Symposium in Paris, chaired by Professors Bousquet and Roche of the University of Paris, recent trends in research, therapy and treatment guidelines for asthma and chronic obstructive pulmonary disease (COPD) were reviewed and discussed by a faculty of expert European and US respiratory physicians. This article reviews five key clinical presentations with particular emphasis given to the importance of small airways in the pathology and treatment of asthma and COPD. Further analysis of the economics of treatment in Europe and the US shows a wide variance in direct and indirect costs.

Citing Articles

Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database.

Price D, Gefen E, Gopalan G, Miglio C, McDonald R, Thomas V Pragmat Obs Res. 2017; 8:69-83.

PMID: 28572742 PMC: 5441674. DOI: 10.2147/POR.S132839.

References

Irvin C, Pak J, Martin R . Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med. 2000; 161(1):50-6. DOI: 10.1164/ajrccm.161.1.9804053. View

Carroll N, Elliot J, Morton A, James A . The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993; 147(2):405-10. DOI: 10.1164/ajrccm/147.2.405. View

Janssens H, de Jongste J, Hop W, Tiddens H . Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest. 2003; 123(6):2083-8. DOI: 10.1378/chest.123.6.2083. View

Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356(8):775-89. DOI: 10.1056/NEJMoa063070. View

In t Veen J, Beekman A, Bel E, Sterk P . Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med. 2000; 161(6):1902-6. DOI: 10.1164/ajrccm.161.6.9906075. View

Brand P, Baraldi E, Bisgaard H, Boner A, Castro-Rodriguez J, Custovic A . Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008; 32(4):1096-110. DOI: 10.1183/09031936.00002108. View

Herland K, Akselsen J, Skjonsberg O, Bjermer L . How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?. Respir Med. 2005; 99(1):11-9. DOI: 10.1016/j.rmed.2004.03.026. View

Bjermer L, Bisgaard H, Bousquet J, Fabbri L, Greening A, Haahtela T . Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ. 2003; 327(7420):891. PMC: 218809. DOI: 10.1136/bmj.327.7420.891. View

Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D . Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005; 25(6):986-91. DOI: 10.1183/09031936.05.00132404. View

10.

Briggs A, Bousquet J, Wallace M, Busse W, Clark T, Pedersen S . Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy. 2006; 61(5):531-6. DOI: 10.1111/j.1398-9995.2006.01038.x. View

11.

Leach C, Davidson P, Boudreau R . Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J. 1999; 12(6):1346-53. DOI: 10.1183/09031936.98.12061346. View

12.

Barnes P, Ito K, Adcock I . Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet. 2004; 363(9410):731-3. DOI: 10.1016/S0140-6736(04)15650-X. View

13.

Newman S . A comparison of lung deposition patterns between different asthma inhalers. J Aerosol Med. 1995; 8 Suppl 3:S21-6; discussion S27. DOI: 10.1089/jam.1995.8.suppl_3.s-21. View

14.

Kim V, Rogers T, Criner G . New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5(4):478-85. PMC: 2645323. DOI: 10.1513/pats.200802-014ET. View

15.

Briggs A, Glick H, Lozano-Ortega G, Spencer M, Calverley P, Jones P . Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J. 2009; 35(3):532-9. DOI: 10.1183/09031936.00153108. View

16.

Agertoft L, Laulund L, Harrison L, Pedersen S . Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatr Pulmonol. 2003; 35(3):192-9. DOI: 10.1002/ppul.10238. View

17.

Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N . Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003; 16(3):249-54. DOI: 10.1089/089426803769017613. View

18.

Price D, Musgrave S, Wilson E, Sims E, Shepstone L, Blyth A . A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health Technol Assess. 2011; 15(21):1-132. DOI: 10.3310/hta15210. View

19.

Smith G, Pell J . Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003; 327(7429):1459-61. PMC: 300808. DOI: 10.1136/bmj.327.7429.1459. View

20.

Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15):1543-54. DOI: 10.1056/NEJMoa0805800. View